A detailed history of Federated Hermes, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Federated Hermes, Inc. holds 198,213 shares of NVO stock, worth $17.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
198,213
Previous 209,711 5.48%
Holding current value
$17.3 Million
Previous $29.9 Million 21.16%
% of portfolio
0.05%
Previous 0.07%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$119.07 - $145.42 $1.37 Million - $1.67 Million
-11,498 Reduced 5.48%
198,213 $23.6 Million
Q2 2024

Aug 08, 2024

SELL
$122.71 - $146.91 $1.56 Million - $1.87 Million
-12,742 Reduced 5.73%
209,711 $29.9 Million
Q1 2024

May 14, 2024

SELL
$102.11 - $135.92 $1.67 Million - $2.23 Million
-16,375 Reduced 6.86%
222,453 $28.6 Million
Q4 2023

Jan 31, 2024

SELL
$87.78 - $105.45 $525,626 - $631,434
-5,988 Reduced 2.45%
238,828 $24.7 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $11.2 Million - $24.5 Million
122,622 Added 100.35%
244,816 $22.3 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $2.03 Million - $2.25 Million
13,038 Added 11.94%
122,194 $19.8 Million
Q1 2023

May 08, 2023

SELL
$132.34 - $159.14 $2.55 Million - $3.07 Million
-19,282 Reduced 15.01%
109,156 $17.4 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $4.58 Million - $6.04 Million
44,632 Added 53.26%
128,438 $17.4 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $50,498 - $61,972
530 Added 0.64%
83,806 $8.35 Million
Q2 2022

Aug 15, 2022

BUY
$103.24 - $121.81 $8.59 Million - $10.1 Million
83,235 Added 203012.2%
83,276 $9.28 Million
Q2 2021

Aug 16, 2021

BUY
$67.66 - $84.76 $2,774 - $3,475
41 New
41 $3,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.